Department of Pharmacognosy, Manipal College of Pharmaceutical sciences, Manipal University, Madhavnagar, Manipal, India.
Pharm Biol. 2012 Oct;50(10):1330-6. doi: 10.3109/13880209.2012.675339.
Gum guggul, a resinous exudate of the plant Commiphora mukul Engl. (Burseraceae), has been found efficacious in the treatment of bone fractures, arthritis, and hyperlipidemic disorders.
The present study is an effort to explore the anti-bone-resorptive potential of the dried methanol extract of the gummy exudate of C. mukul (MECM) in ovariectomized rat model.
The animals were randomly divided into five groups of equal size (n = 6). Animals in all the groups were ovariectomized except group 1, which was sham operated. Groups 3, 4 and 5 were treated with Raloxifene, MECM 250 mg/kg and MECM 500 mg/kg, respectively. The 2nd group was fed with vehicle.
biochemical estimations, viz., alkaline phosphatase (ALP), tartarate resistant acid phosphatase (TRAP), serum calcium (Ca); biomechanical evaluations, and histopathological examinations.
The LD(50) of MECM was found to be > 2500 mg/kg orally. A significant elevation was observed in the ALP, TRAP, Ca and cholesterol levels in the 2nd group with a significant reduction in biomechnical strength. Groups 3, 4 and 5, showed a significant reduction in TRAP and ALP levels (p < 0.001). The Ca levels were normalized in the groups 4 and 5, while cholesterol levels dropped in group 5. The bone strength, however, was normalized in all the groups (p < 0.001) along with the histopathology.
Findings suggested a significant gain in bone strength and nearly complete restoration of bone microarchitecture along with lowered levels of TRAP indicating the anti-bone resorptive potential of the extract.
乳香,是一种植物 Commiphora mukul Engl.(Burseraceae)的树脂状渗出物,已被证明在治疗骨折、关节炎和高脂血症方面有效。
本研究旨在探索 Commiphora mukul 的干甲醇提取物(MECM)对去卵巢大鼠模型的抗骨吸收潜力。
将动物随机分为 5 组,每组 6 只(n=6)。除第 1 组为假手术外,所有组均进行卵巢切除术。第 3、4 和 5 组分别用雷洛昔芬、MECM 250mg/kg 和 MECM 500mg/kg 治疗。第 2 组给予载体。
生化测定,即碱性磷酸酶(ALP)、耐酒石酸酸性磷酸酶(TRAP)、血清钙(Ca);生物力学评估和组织病理学检查。
MECM 的 LD50 口服大于 2500mg/kg。第 2 组的 ALP、TRAP、Ca 和胆固醇水平显著升高,生物力学强度显著降低。第 3、4 和 5 组 TRAP 和 ALP 水平显著降低(p<0.001)。第 4 和第 5 组的 Ca 水平正常化,而第 5 组的胆固醇水平下降。所有组的骨强度均正常化(p<0.001),同时组织病理学也正常化。
研究结果表明,提取物具有显著的增加骨强度和几乎完全恢复骨微观结构的作用,同时降低 TRAP 水平,提示其具有抗骨吸收的潜力。